Michelle Mishoe
Icahn School of Medicine at Mount Sinai
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michelle Mishoe.
Allergy | 2007
Kirsi M. Järvinen; Kirsten Beyer; Leticia Vila; Ludmilla Bardina; Michelle Mishoe; Hugh A. Sampson
Background: Approximately two‐thirds of egg‐allergic infants become tolerant within the first 5 years of life.
Pediatric Allergy and Immunology | 2017
Maureen Egan; Tricia D. Lee; Jade Andrade; Galina Grishina; Michelle Mishoe; Gustavo Gimenez; Hugh A. Sampson; Supinda Bunyavanich
class, may differ in immune reactivity only for the characteristics of the side chains. Thus, the reactivity of the immune system to one compound of one drug class may result in unexpected cross-reactivity to similar compounds. This crossreactivity of the immune system with similar drugs depends on the structural affinity and precursor frequency of drug-specific T (or B) cells. Drugs, which may differ in only an OH group, might be result more cross-reactive than drugs which are different in a longer side chain (9). Cross-reactivity in IgEmediated reactions is more problematic, since in sensitized individuals, small amounts of drugs (which normally behave as haptens) may induced a cross-link drug-specific IgE on mast cells by hapten-carrier complexes. Therefore, acute symptoms reflecting cross-reactivity may arise even if the amount of drug is very low and the level of cross-reactivity is limited and restricted to a small part of drug-specific IgE. Other studies would be needed about possible cross-reactivity of midazolam with other drugs or other substances occurring in nature (10).This case also confirms that skin reactivity persists for a longer period than circulating IgE, and is therefore more sensitive. In conclusion, this case demonstrates that midazolam can induce hypersensitivity reactions. Accordingly, we advise that this possibility should be considered when midazolam is administered during perioperative period in pediatric patients even if the clinical history is not indicative.
The Journal of Allergy and Clinical Immunology | 2010
W. Slotkin; I. Lopez Exposito; A. Castillo; Michelle Mishoe; Nan Yang; B. Liang; Xiu-Min Li
Trabajo presentado al American Academy of Allergy, Asthma and Immunology Annual Meeting celebrado en Nueva Orlenas (US) del 26 de febrero al 2 de marzo de 2010.
The Journal of Allergy and Clinical Immunology | 2004
Kirsten Beyer; Kirsi-Marjut Järvinen; Ludmilla Bardina; Michelle Mishoe; Kristiina Turjanmaa; Bodo Niggemann; Staffan Ahlstedt; Lennart Venemalm; Hugh A. Sampson
The Journal of Allergy and Clinical Immunology | 2008
Kirsten Beyer; Danna Chung; Gabriele Schulz; Michelle Mishoe; Bodo Niggemann; Ulrich Wahn; Hugh A. Sampson
The Journal of Allergy and Clinical Immunology: In Practice | 2015
Tricia D. Lee; Gustavo Gimenez; Galina Grishina; Michelle Mishoe; Hugh A. Sampson; Supinda Bunyavanich
The Journal of Allergy and Clinical Immunology | 2003
Kirsi-Marjut Järvinen; Kirsten Beyer; Ludmilla Bardina; Michelle Mishoe; Hugh A. Sampson
The Journal of Allergy and Clinical Immunology | 2018
Michele N. Pham; Jade Andrade; Michelle Mishoe; Tricia D. Lee; Supinda Bunyavanich
The Journal of Allergy and Clinical Immunology | 2017
Maureen Egan; Tricia D. Lee; Jade Andrade; Galina Grishina; Michelle Mishoe; Gustavo Gimenez; Hugh A. Sampson; Supinda Bunyavanich
/data/revues/00916749/v122i2/S0091674908011263/ | 2011
Kirsten Beyer; Danna Chung; Gabriele Schulz; Michelle Mishoe; Bodo Niggemann; Ulrich Wahn; Hugh A Sampson